The day-to-day management, as well as the representation of the EBF as far as the day-to-day management and external representation is concerned is delegated from the Board of Directors to a Steering Committee (SC) elected amongst the Pharma members. SC composition reviewed and/or confirmed at strategy meeting of uneven year. The SC currently consists of the following 5 people :

Philip Timmerman, Belgium, Chairman of the EBF

Marianne Scheel-Fjording, Novo Nordisk, Denmark

Magnus Knutsson, Ferring Pharmaceuticals, Denmark

Joanna Goodman, MedImmune, United Kingdom

Steve White, GSK, United Kingdom

Copyright 2016 EBF
EBF vzw is the registered non-profit organisation of the European Bioanalysis Forum
Read more about EBF at our community site: www.europeanbioanalysisforum.eu